Quercetin

What is quercetin?

Quercetin is one of the most versatile compounds in the longevity supplement stack — it does several genuinely useful things simultaneously. Most people first encounter it as the non-prescription half of the D+Q senolytic combination (where it works alongside dasatinib to clear senescent cells). But quercetin has a rich independent pharmacology that makes it worth understanding on its own terms, not just as a dasatinib companion.

As a standalone daily supplement, quercetin’s most clinically important properties are: anti-inflammatory (NF-κB inhibition, reducing pro-inflammatory cytokine production), PCSK9 downregulation (a cell-level mechanism it shares with expensive injectable biologics, though quercetin’s effect is far more modest and not yet proven to lower LDL clinically), mast cell stabilisation (relevant for histamine intolerance, allergies, and MCAS), antiviral activity via zinc ionophore function (quercetin carries zinc into cells where it inhibits viral RNA polymerase), and senomorphic effects (reducing the inflammatory secretory output of senescent cells without necessarily killing them). These independent properties are why many users take quercetin daily rather than only during D+Q senolytic pulses.

As a senolytic in the D+Q combination, quercetin contributes PI3K inhibition and BCL-XL suppression that complement dasatinib’s kinase inhibition, covering a broader range of senescent cell types than either compound alone. Quercetin’s standalone senolytic activity is real but weaker than fisetin as a standalone agent — it’s the combination with dasatinib that produces the strongest clinical senolytic data.

Bioavailability is the key practical consideration. Standard quercetin has approximately 1% oral bioavailability due to limited solubility and rapid gut metabolism. Quercetin phytosome (quercetin complexed with sunflower lecithin phospholipids, branded as Quercefit) achieves approximately 20x higher plasma quercetin levels than standard quercetin at the same dose. For any application where systemic quercetin levels matter — cardiovascular, senolytic — phytosome is strongly preferred.

How it works

Senolytic — PI3K and BCL-XL Inhibition

In the D+Q protocol, quercetin contributes two primary mechanisms: PI3K/AKT survival pathway inhibition (reducing the pro-survival signalling that senescent cells depend on) and BCL-XL inhibitory activity (reducing the anti-apoptotic protein that keeps senescent cells alive). These complement dasatinib’s kinase inhibition, covering senescent cell types that dasatinib does not fully address alone — particularly senescent human umbilical vein endothelial cells and NK cells.

Senomorphic — SASP Reduction

Beyond killing senescent cells, quercetin reduces the inflammatory secretory output of senescent cells that remain — the senomorphic effect. It inhibits NF-κB and reduces SASP factors including IL-6, IL-1β, TNF-α, and MMP-3. This daily anti-inflammatory effect on SASP is relevant even for users who do not run formal D+Q senolytic pulses — regular quercetin supplementation may reduce the chronic low-grade inflammation driven by accumulating senescent cells.

PCSK9 Downregulation — Cardiovascular (mechanistic)

In cultured human liver cells, quercetin (as quercetin-3-glucoside) lowers PCSK9 secretion and raises LDL-receptor levels — the same target as the injectable PCSK9 antibodies evolocumab and alirocumab, though quercetin’s effect is far more modest and demonstrated in vitro. By reducing PCSK9, quercetin lets LDL receptors persist longer on hepatocyte surfaces, which should increase LDL clearance. It’s a promising, mechanistically grounded angle — but the human blood-pressure and lipid trials to date did not measure PCSK9, so a meaningful LDL-lowering effect in humans is not yet proven.

Zinc Ionophore — Antiviral

Quercetin acts as a zinc ionophore — it facilitates zinc transport across cell membranes, raising intracellular zinc. Intracellular zinc inhibits viral RNA-dependent RNA polymerase (RdRp), the enzyme many viruses including coronaviruses and influenza use for replication. The quercetin + zinc combination became widely used during COVID-19 for this reason — the quercetin carries zinc into cells; zinc blocks viral replication.

What the research shows

What the community reports

The quercetin community splits into two distinct use patterns — daily low-dose users and periodic high-dose D+Q practitioners — with meaningful overlap.

Common misconceptions